Ren Min Ri Bao Hai Wai Ban·2025-04-28 22:36Core Viewpoint - The article emphasizes the importance of the Chinese market for American companies, highlighting their continued investment and collaboration despite the challenges posed by U.S. tariffs and trade policies [1][5]. Group 1: Investment and Growth Potential - Pfizer plans to invest $1 billion in China by 2030, having established new research and innovation centers in Beijing and Hangzhou [2]. - From 2020 to 2023, American companies in China experienced a compound annual growth rate of 12% in revenue, significantly outpacing the global market growth rate of 1.3% [2]. Group 2: Strategic Value of the Chinese Market - The strategic value of the Chinese market for U.S. companies is underscored by its large consumer base of over 1.4 billion people and a growing middle-income group exceeding 400 million [4]. - China's complete industrial chain and supply chain stability attract many U.S. companies, with Apple being a prime example of leveraging China's manufacturing capabilities [3][4]. Group 3: Impact of U.S. Tariffs - U.S. tariffs have significantly increased operational costs for American companies, with Apple experiencing over a 50% cost increase for iPhones due to tariffs [7]. - The imposition of tariffs has created uncertainty in trade policies, disrupting global supply chains and negatively impacting the operational efficiency of U.S. companies [7][8]. Group 4: Opportunities from China's Opening Up - China is accelerating its opening up, with 155 pilot tasks aimed at expanding service industry access, providing new opportunities for foreign enterprises [9][11]. - The implementation of the Regional Comprehensive Economic Partnership (RCEP) is expected to facilitate trade and investment, allowing foreign companies to leverage China as a hub for accessing emerging markets [11][12].